Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest EcoR1 Capital, LLC Stock Portfolio

$3.95Billion– No. of Holdings #57

EcoR1 Capital, LLC Performance:
2024 Q1: 3.16%YTD: 3.16%2023: 4.57%

Performance for 2024 Q1 is 3.16%, and YTD is 3.16%, and 2023 is 4.57%.

About EcoR1 Capital, LLC and 13F Hedge Fund Stock Holdings

EcoR1 Capital, LLC is a hedge fund based in SAN FRANCISCO, CA. On 29-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $4.7 Billions. In it's latest 13F Holdings report, EcoR1 Capital, LLC reported an equity portfolio of $4 Billions as of 31 Mar, 2024.

The top stock holdings of EcoR1 Capital, LLC are APLS, PRTA, ARVN. The fund has invested 16.9% of it's portfolio in APELLIS PHARMACEUTICALS INC and 7.3% of portfolio in PROTHENA CORP PLC.

The fund managers got completely rid off MIRATI THERAPEUTICS INC (MRTX), ARGENX SE (ARGX) and GRAPHITE BIO INC (GRPH) stocks. They significantly reduced their stock positions in EDGEWISE THERAPEUTICS INC (EWTX), ATEA PHARMACEUTICALS INC (AVIR) and PROQR THRAPEUTICS N V (PRQR). EcoR1 Capital, LLC opened new stock positions in CRISPR THERAPEUTICS AG (CRSP), ADAPTIMMUNE THERAPEUTICS PLC (ADAP) and CELLDEX THERAPEUTICS INC (CLDX). The fund showed a lot of confidence in some stocks as they added substantially to CAREMAX INC (CMAX), MORPHIC HLDG INC (MORF) and SAREPTA THERAPEUTICS INC (SRPT).
EcoR1 Capital, LLC Equity Portfolio Value
Last Reported on: 15 May, 2024

EcoR1 Capital, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that EcoR1 Capital, LLC made a return of 3.16% in the last quarter. In trailing 12 months, it's portfolio return was 12.69%.

New Buys

Ticker$ Bought
crispr therapeutics ag94,693,100
adaptimmune therapeutics plc43,298,400
celldex therapeutics inc27,280,500
lenz therapeutics inc27,237,600
nkarta inc21,620,000
vaxcyte inc20,493,000
madrigal pharmaceuticals inc20,028,000
avidity biosciences inc19,333,300

New stocks bought by EcoR1 Capital, LLC

Reductions

Ticker% Reduced
edgewise therapeutics inc-64.21
atea pharmaceuticals inc-12.15
proqr thrapeutics n v-3.21

EcoR1 Capital, LLC reduced stake in above stock

Sold off

Ticker$ Sold
mirati therapeutics inc-434,573,000
ngm biopharmaceuticals inc-2,049,460
graphite bio inc-22,370,700
spyre therapeutics inc-19,089,900
allakos inc-2,044,500
argenx se-114,508,000
phathom pharmaceuticals inc-1,812,120
tyra biosciences inc-1,897,640

EcoR1 Capital, LLC got rid off the above stocks

Sector Distribution

EcoR1 Capital, LLC has about 87.5% of it's holdings in Healthcare sector.

Sector%
Healthcare87.5
Others12.5

Market Cap. Distribution

EcoR1 Capital, LLC has about 6.3% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP39.8
SMALL-CAP37.4
UNALLOCATED12.5
LARGE-CAP6.3
MICRO-CAP3.8

Stocks belong to which Index?

About 55.7% of the stocks held by EcoR1 Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200055.7
Others44.3
Top 5 Winners (%)%
GBIO
generation bio co
146.7 %
NUVB
nuvation bio inc
141.1 %
NUVB
nuvation bio inc
141.1 %
IMNM
immunome inc
130.7 %
MRSN
mersana therapeutics inc
93.1 %
Top 5 Winners ($)$
IMNM
immunome inc
54.2 M
CRNX
crinetics pharmaceuticals in
41.9 M
MRSN
mersana therapeutics inc
41.8 M
NUVB
nuvation bio inc
40.9 M
KURA
kura oncology inc
40.4 M
Top 5 Losers (%)%
PMVP
pmv pharmaceuticals inc
-45.2 %
ACAD
acadia pharmaceuticals inc
-41.0 %
CMAX
caremax inc
-39.2 %
PRTA
prothena corp plc
-31.8 %
ALEC
alector inc
-24.6 %
Top 5 Losers ($)$
PRTA
prothena corp plc
-134.0 M
ACAD
acadia pharmaceuticals inc
-76.8 M
TNGX
tango therapeutics inc
-26.1 M
APLS
apellis pharmaceuticals inc
-12.9 M
ALEC
alector inc
-8.0 M

EcoR1 Capital, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of EcoR1 Capital, LLC

EcoR1 Capital, LLC has 57 stocks in it's portfolio. About 61.1% of the portfolio is in top 10 stocks. PRTA proved to be the most loss making stock for the portfolio. IMNM was the most profitable stock for EcoR1 Capital, LLC last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions